Building a Better Bottle

February 2011
Pharmaceutical Representative;Feb2011, Vol. 41 Issue 2, p9
The article presents the proposed standards published by the U.S. Pharmacopeia Inc. for prescription drug labels.


Related Articles

  • GLUTEN-FREE LABELING GETS CLARIFICATION FROM FDA.  // Quality Progress;Sep2013, Vol. 46 Issue 9, p14 

    The article reports on a new standard set by the U.S. Food and Drug Administration that will require products labeled "gluten-free" to contain less than 20 parts per million of gluten, a new definition that aims to help people with celiac disease make food choices with confidence.

  • Why we need mass serialization -- now! Noon, Gary // Pharmaceutical Technology Europe;Jun2009, Vol. 21 Issue 6, p21 

    The article focuses on the benefits of mass serialization in the pharmaceutical industry. It mentions that mass serialization is the method of adding machine-readable codes with serial number to individual packs of medicines, enabling product authentication at the point of dispense (POD). The...

  • United States proposes universal labelling standards for prescriptions. Walkinshaw, Erin // CMAJ: Canadian Medical Association Journal;7/12/2011, Vol. 183 Issue 10, pE635 

    The article reports on the proposal of the U.S. federal government for universal labelling standards of prescriptions. It mentions that the federal government had proposed the standards to reduce nonadherence and medication errors. It states that the standards would change the labelling on...

  • NEW SUNSCREEN STANDARDS.  // SupermarketNews;Jun2014, Vol. 6 Issue 6, p9 

    The article reports on the standards for sunscreens introduced by standard setting group Australia New Zealand Therapeutic Products Agency in June 2013 which classify as medicines and regulate them under compliance requirements.

  • Revision of monograph on tablets.  // WHO Drug Information;2011, Vol. 25 Issue 2, p139 

    The article reports on a revised monograph on tablets which was adopted by the 44th World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations in October of 2009 for addition to the organization's publication "The International Pharmacopoeia." The monograph...

  • International Reference Standards.  // WHO Drug Information;2005, Vol. 19 Issue 1, p27 

    The article presents information on international reference standards of WHO Expert Committee on Biological Standardization. The information is given in tabular form. The information covers, antigens and related substances, blood products and related substances, and others.

  • Recent changes to FDA-approved labeling.  // American Journal of Health-System Pharmacy;12/1/2002, Vol. 59 Issue 23, p2284 

    Discusses the changes made by the U.S. Food and Drug Administration's on certain drug labels. Estradiol; Fluticasone propionate; Metaxalone; Gabapentin; Tretinoin microspheres; Beclomethasone dipropionate.

  • Private-Label Products: Your Patients Already Know.  // Review of Optometry;5/15/2002, Vol. 139 Issue 5, p40 

    Focuses on the importance of private-labeling of medicines. Advantages of product labeling on patients; Awareness of patients on the purpose of labeling.

  • Label Literacy.  // Current Health 2;Nov2007, Vol. 34 Issue 3, p6 

    The article explains the parts of a drug label.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics